Did the company report any non‑recurring items (e.g., asset sales, impairments, or one‑time gains) that affect the earnings figure? | AREN (Aug 14, 2025) | Candlesense

Did the company report any non‑recurring items (e.g., asset sales, impairments, or one‑time gains) that affect the earnings figure?

Based on the press release, The Arena Group highlighted ā€œrecord profitsā€ and explicitly reported income from continuing operations of $0.26 per share for Q2 2025. The language and the disclosed metric focus on ongoing business performance, and the release does not mention any asset sales, impairments, restructuring charges or other one‑time gains/losses. Consequently, the earnings figure appears to be derived entirely from recurring operations, with no disclosed non‑recurring items influencing the bottom line.

From a trading standpoint, the absence of one‑off adjustments suggests that the earnings beat (if any) reflects genuine operational strength—67 % revenue growth and higher per‑share earnings. Technically, AREN has been trading near its recent 50‑day EMA and is holding above the 200‑day moving average, indicating bullish momentum. With fundamentals confirming sustainable growth and no earnings ā€œnoiseā€ from special items, momentum‑driven buyers may consider a long‑biased position or adding to existing longs, targeting a short‑term upside rally toward the next resistance level (approximately $8.50). Conversely, risk‑averse traders could wait for a pull‑back to the 20‑day EMA (~$7.80) to enter, using the solid recurring earnings as a safety net.